Low stroke rate and few thrombo-embolic events after heartmate II implantation under mild anticoagulation

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 2, 2012, Pages 319-323

  Menon, Ares K ^a   Götzenich, Andreas ^a   Sassmannshausen, Helena ^a   Haushofer, Marcus ^a   Autschbach, Rüdiger ^a   Spillner, Jan W ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Assisted circulation; Congestive heart failure; Continuous flow left ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEARTMATE II; HEPARIN; PHENPROCOUMON; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIODYSPLASIA; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHEST TUBE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC PUMP THROMBOSIS; LEFT VENTRICULAR ASSIST DEVICE; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY ATHEROSCLEROSIS; SURVIVAL RATE; THORACOTOMY; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME; HEART ASSIST DEVICE; MIDDLE AGED;

ANTICOAGULANTS; ASPIRIN; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEPARIN; HUMANS; MALE; MIDDLE AGED; PHENPROCOUMON; STROKE; THROMBOEMBOLISM;

EID: 84871673891     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr312     Document Type: Article

References (11)

1. Stüber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG et al. HeartMate II left ventricular assist device: early European experience. Eur J Cardiothorac Surg 2008;34:289-94.
2. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
3. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361: 2241-51.
4. Slaughter MS, Naka Y, John R, Boyle A, Conte JV, Russell SD et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant 2010;29:616-24.
5. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009;28:881-7.
6. Scherer M, Sirat AS, Moritz A, Martens S. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 2011;39:939-44; discussion 944.
7. Haneya A, Philipp A, Puehler T, Rupprecht L, Kobuch R, Hilker M et al. Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg 2011;41:219-23.
8. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008;33:679-84.
9. Kloviate J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Cardiol 2009;53:2162-7.
10. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357-61.
11. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010;56: 1207-13.